RT Conference Proceedings
T1 Avelumab first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone with 1L chemotherapy (CTx) for advanced urothelial carcinoma (UC): Subgroup analyses from JAVELIN Bladder 100
A1 Grivas, P.
A1 Park, S. H.
A1 Voog, E.
A1 Caserta, C.
A1 Perez Valderrama, B.
A1 Gurney, H.
A1 Kalofonos, H.
A1 Radulovic, S.
A1 Demey, W.
A1 Ullen, A.
A1 Loriot, Y.
A1 Sridhar, S. S.
A1 Tsuchiya, N.
A1 Kopyltsov, E.
A1 Gupta, S.
A1 Huang, B.
A1 Costa, N.
A1 Blake-Haskins, J. A.
A1 di Pietro, A.
A1 Powles, T. B.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/27220
UL https://hdl.handle.net/10668/27220
LA en
DS RISalud
RD Apr 19, 2025